Company Overview
Snapshot
Founded in February 2020 by Sam Weitzman, Yaakov Diminsky, and Yohan Ouzan-Van Der Mark, NanoScout operates with 1-10 employees. The company recently completed its graduation from the Arc Innovation Center, signaling its readiness for further development and market entry.
Business overview
NanoScout specializes in nano-detection technologies and services, providing scalable solutions for various industries. Its core offering is a cloud-based artificial intelligence software that diagnoses and solves problems at the nanoscale. By leveraging AI and proprietary chemical protocols, NanoScout performs high-end diagnostics and quality assurance, detecting impurities and infections based on a single pathogen's nano-morphology. The company aims to enable fast, accurate, and low-cost nano-morphology testing for diagnostics and quality assurance, serving enterprises, healthcare providers, and academia within the Digital Health and Medical Technologies sectors.
Log in to access full profile ›Company Intelligence Q&A
- What is NanoScout's primary focus?
- NanoScout focuses on providing nano-detection technologies and services, offering scalable solutions for various industries to find, solve, and diagnose problems at the nano scale.
- What technology does NanoScout utilize?
- NanoScout utilizes cloud-based artificial intelligence combined with proprietary sample preparation protocols to detect minute details of pathogens and products, enabling high-end diagnostics and quality assurance.
- Who are the founders of NanoScout?
- NanoScout was founded by Sam Weitzman, Yaakov Diminsky, and Yohan Ouzan-Van Der Mark.
- When was NanoScout founded?
- NanoScout was founded in February 2020.
- What is NanoScout's mission?
- NanoScout's mission is to enable a new age of fast, accurate, and low-cost testing of nano-morphology for diagnostics and quality assurance.